Psychopharmacology

The drug is in development for the treatment of acute depressive disorders and depression with suicidality.

The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.

In this CME article, learn how to apply novel treatment approaches for patients with bipolar depression.

From the unique challenges of treating physician-patients to updates on MDMA and psilocybin research and access, here are highlights from the week in Psychiatric Times.

An important adverse effect of SRIs: their association with increased bleeding.

Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.

From the cardiac adverse effects of lithium to the road to over-the-counter naloxone, here are highlights from the week in Psychiatric Times.

What is the buzz about the power of artificial intelligence?

When should you monitor electrocardiograms in patients taking lithium?

In the case of antidepressants, a few recent articles may make it tempting to throw the baby out with the bathwater. But on close examination, that would be a mistake on many levels...

From the relationship between psychotic disorders and dementia risk to the major differences between bipolar I and bipolar II, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the October 2022 issue of Psychiatric Times.

What are the elements of a good meta-analysis?

What is the effect of cannabis use on adherence to medications in patients with psychosis?

From the at-home ketamine experience to the Wit v United Behavioral Health reversal, here are highlights from the week in Psychiatric Times.

"As clinicians who took an oath to 'do no harm,' we must educate the public about the dangers and non–standard of care of the growing practice of at-home ketamine."

Researchers performed a nationwide cohort study of the use of calcium-channel blockers and adenosine modulators and risk of hospitalization in bipolar disorder.

From older age bipolar disorder to the relationship between antidepressants and emotional numbing, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the September 2022 issue of Psychiatric Times.

From ketamine response to differences between mTBI and concussion, here are highlights from the week in Psychiatric Times.

Will it hurt my baby? Researchers investigated associations between first trimester exposure to second-generation antipsychotics and major congenital malformations.

The underlying neural mechanisms identified may help clinicians better understand ketamine response in human patients.

Risk of suicide attempt is higher among adults, women.

"It would be naïve to believe that targeting a single neurotransmitter, receptor, or circuit in the brain will cure any psychiatric or neurological disorder. However, we would be remiss if we did not try."

What lead to this teen being prescribed 10 psychiatric drugs and why is it a symptom of a larger problem?